Nishant C. Saxena's most recent trade in Corbus Pharmaceuticals Holdings Inc was a trade of 9,000 Common Stock, par value $0.0001 per share done at an average price of $7.6 . Disclosure was reported to the exchange on June 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corbus Pharma Holdings Inc | Nishant C. Saxena | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 7.58 per share. | 02 Jun 2026 | 9,000 | 75,300 (0%) | 0% | 7.6 | 68,220 | Common Stock, par value $0.0001 per share |
| Corbus Pharma Holdings Inc | Nishant C. Saxena | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 7.33 per share. | 02 Jun 2026 | 4,500 | 66,300 (0%) | 0% | 7.3 | 32,999 | Common Stock, par value $0.0001 per share |
| Corbus Pharma Holdings Inc | Nishant C. Saxena | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 192,300 | 192,300 | - | - | Stock options (right to buy) | |
| Corbus Pharma Holdings Inc | Nishant C. Saxena | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2026 | 58,300 | 61,800 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share |